Greater Cannabis Company (GCAN) EBIT Growth (1y) (2018 - 2026)
Greater Cannabis Company (GCAN) EBIT Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 25.63% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.30% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -319.32% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -14.89% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 97.23% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 719.49% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.25% |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - | 23.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.34% |
| Dec 31, 2025 | -43.01% |
| Sep 30, 2025 | 7.49% |
| Jun 30, 2025 | -22.91% |
| Mar 31, 2025 | -11.77% |
| Dec 31, 2024 | 14.54% |
| Sep 30, 2024 | 19.86% |
| Jun 30, 2024 | 5.19% |
| Mar 31, 2024 | 1.31% |
| Dec 31, 2023 | -4.16% |
| Sep 30, 2023 | -2.35% |
| Jun 30, 2023 | 3.79% |
| Mar 31, 2023 | 6.98% |
| Dec 31, 2022 | 64.81% |
| Sep 30, 2022 | 33.68% |
| Jun 30, 2022 | 31.12% |
| Mar 31, 2022 | 50.80% |
| Dec 31, 2021 | -124.36% |
| Sep 30, 2021 | -4.81% |
| Jun 30, 2021 | 23.72% |